Open-label trial demonstrates pain reduction in oral mucositis via methylene blue mouthwash, suggesting further investigation is needed.
In this non-randomized study, MB mouthwash was associated with short-term pain reductions in OM-related pain similar to standard-of-care mouthwash. These findings support feasibility and tolerability and underscore the need for larger randomized trials.
No takes yet. Share an insight, caveat, or question.
Karow et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: